TD Cowen Downgrades Inozyme Pharma Inc. (INZY) to Hold Following Takeover May 16, 2025 04:18PM
Inozyme Pharma to Present at the TD Cowen 45th Annual Health Care Conference Feb 24, 2025 08:30AM
TD Cowen Reiterates Buy Rating on Inozyme Pharma Inc. (INZY) Oct 25, 2024 07:27AM
Inozyme Pharma to Participate in the TD Cowen 44th Annual Health Care Conference Feb 26, 2024 08:30AM
Inozyme Pharma, Inc. Announces Closing of Public Offering of Common Stock Aug 1, 2023 04:01PM


Jul 28, 2023 05:51AM Inozyme Pharma Inc. (INZY) Prices 12.5M Share Offering at $4.80/sh
Jul 27, 2023 11:20PM Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock
Jul 27, 2023 04:34PM Inozyme Pharma (INZY) Announces $60M Proposed Offering of Common Stock
Jul 27, 2023 04:33PM Inozyme Pharma, Inc. Announces Proposed Offering of Common Stock
Mar 1, 2023 08:30AM Inozyme Pharma to Participate in the Cowen 43rd Annual Health Care Conference
Apr 14, 2022 08:17AM Inozyme Pharma Inc. (INZY) Prices $73M Share and Warrant Offering at $3.69/sh
Apr 14, 2022 08:16AM Inozyme Pharma Announces $73 Million Underwritten Offering Priced At-the-Market
Mar 1, 2022 07:30AM Inozyme Pharma to Present at Cowen 42nd Annual Health Care Conference
Aug 18, 2020 06:28AM UPDATE: Cowen Starts Inozyme Pharma Inc. (INZY) at Outperform
Jul 30, 2020 04:01PM Inozyme Pharma Announces Closing of Initial Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
Jul 24, 2020 11:54AM Inozyme Pharma (INZY) IPO Opens 30% Higher
Jul 24, 2020 05:49AM Inozyme Pharma Inc. (INZY) Prices 7M Share IPO at $16/Sh
Jul 23, 2020 09:30PM Inozyme Pharma Announces Pricing of Initial Public Offering